Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

July 2013 - FRMC

Department
Foam Approved for Plaque Psoriasis of the Scalp
07/22/2013
The FDA approved Sorilux™ (calcipotriene) Foam as a topical treatment for adults with plaque psoriasis of the scalp.
The FDA approved Sorilux™ (calcipotriene) Foam as a topical treatment for adults with plaque psoriasis of the scalp.
The FDA approved Sorilux™...
07/22/2013
First Report Managed Care
Department
Oral Medication to Treat Myelofibrosis
07/22/2013
The FDA approved Jakafi® (ruxolitinib) in November 2011 to treat patients with myelofibrosis, a bone marrow disease. 
The FDA approved Jakafi® (ruxolitinib) in November 2011 to treat patients with myelofibrosis, a bone marrow disease. 
The FDA approved...
07/22/2013
First Report Managed Care
Department
Simeprevir Phase 3 Trial Results
07/22/2013

Tim Casey

Tim Casey
Orlando—Treatment-naïve patients with hepatitis C who took 150 mg of simeprevir once daily in combination with peginterferon and ribavirin had a significantly better sustained virological response (SVR) rate compared with those taking...
Orlando—Treatment-naïve patients with hepatitis C who took 150 mg of simeprevir once daily in combination with peginterferon and ribavirin had a significantly better sustained virological response (SVR) rate compared with those taking...
Orlando—Treatment-naïve patients...
07/22/2013
First Report Managed Care
Duration of Treatment with Linaclotide
07/22/2013

Tim Casey

Tim Casey
Patients with irritable bowel syndrome whose symptoms improved after 4 weeks of treatment with linaclotide were highly likely to continue feeling better at week 12.
Patients with irritable bowel syndrome whose symptoms improved after 4 weeks of treatment with linaclotide were highly likely to continue feeling better at week 12.
Patients with irritable bowel...
07/22/2013
First Report Managed Care
Lifetime Burden of Inaccurate HER2 Testing
07/22/2013

Tori Socha

Tori Socha
Chicago—Among the estimated 26,870 women who were diagnosed with breast cancer in 2012, 20% had tumors that overexpress the human epidermal growth factor 2 (HER2) gene, a marker of severity of disease that can influence therapy selection. All...
Chicago—Among the estimated 26,870 women who were diagnosed with breast cancer in 2012, 20% had tumors that overexpress the human epidermal growth factor 2 (HER2) gene, a marker of severity of disease that can influence therapy selection. All...
Chicago—Among the estimated...
07/22/2013
First Report Managed Care

Department

Conference Insider
Treatment Options for Ulcerative Colitis
07/22/2013

Tim Casey

Tim Casey
Orlando—Clinicians have numerous options to treat patients with ulcerative colitis, a form of inflammatory bowel disease. The therapies include 5-amino-salacylic acid, thiopurine, and anti-tumor necrosis factor (TNF) agents such as...
Orlando—Clinicians have numerous options to treat patients with ulcerative colitis, a form of inflammatory bowel disease. The therapies include 5-amino-salacylic acid, thiopurine, and anti-tumor necrosis factor (TNF) agents such as...
Orlando—Clinicians have numerous...
07/22/2013
First Report Managed Care
Conference Insider
Linaclotide and Improved Abdominal and Bowel Symptoms
07/22/2013

Tim Casey

Tim Casey
Orlando—An analysis of two phase 3 trials found that a higher percentage of patients who received linaclotide to treat abdominal and bowel symptoms had clinically meaningful improvement compared with a group receiving placebo. The clinically...
Orlando—An analysis of two phase 3 trials found that a higher percentage of patients who received linaclotide to treat abdominal and bowel symptoms had clinically meaningful improvement compared with a group receiving placebo. The clinically...
Orlando—An analysis of two phase...
07/22/2013
First Report Managed Care
Conference Insider
Extended Duration Thromboprophylaxis for Venous Thromboembolism
07/22/2013

Tim Casey

Tim Casey
Orlando—Patients with venous thromboembolism (VTE) who took extended duration thromboprophylaxis had an incremental cost-effectiveness ratio of $8123 per quality-adjusted life year (QALY), according to a cost-effectiveness decision tree...
Orlando—Patients with venous thromboembolism (VTE) who took extended duration thromboprophylaxis had an incremental cost-effectiveness ratio of $8123 per quality-adjusted life year (QALY), according to a cost-effectiveness decision tree...
Orlando—Patients with venous...
07/22/2013
First Report Managed Care
Conference Insider
Readmission Rates and Gastrointestinal Surgeries
07/22/2013

Tim Casey

Tim Casey
Orlando—After controlling for patient and operative factors, the authors in a study of patients undergoing major gastrointestinal surgeries found numerous factors were associated with an increased risk of 30-day unplanned readmissions.
Orlando—After controlling for patient and operative factors, the authors in a study of patients undergoing major gastrointestinal surgeries found numerous factors were associated with an increased risk of 30-day unplanned readmissions.
Orlando—After controlling for...
07/22/2013
First Report Managed Care
Conference Insider
Colorectal Cancer Screening and Colonoscopies
07/22/2013

Tim Casey

Tim Casey
Orlando—As screening rates for colorectal cancer have increased in recent years, the incidence and death rates due to the disease have declined. Still, approximately 22 million people in the United States have never been screened, and the...
Orlando—As screening rates for colorectal cancer have increased in recent years, the incidence and death rates due to the disease have declined. Still, approximately 22 million people in the United States have never been screened, and the...
Orlando—As screening rates for...
07/22/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

Abuse and Misuse of Opioid Medications
09/19/2013

Tim Casey

Tim Casey
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been proven effective in treating chronic pain; however, they are also associated with misuse, abuse, and diversion. 
Opioid medications have been...
09/19/2013
First Report Managed Care
News
Melanoma Drugs Show Some Success
06/21/2011
06/21/2011
First Report Managed Care
News
Changes in Appearance of Medicine Effects Patient Adherence
07/15/2014
A recent study found that individuals are more likely to stop taking their medication after a heart attack if the appearance of their medication changes without explanation [Ann Intern Med. 2014;161(2):96-103]. Aaron S. Kesselheim, MD, JD,...
A recent study found that individuals are more likely to stop taking their medication after a heart attack if the appearance of their medication changes without explanation [Ann Intern Med. 2014;161(2):96-103]. Aaron S. Kesselheim, MD, JD,...
A recent study found that...
07/15/2014
First Report Managed Care
News
New FDA Commissioner Confirmed by Senate
05/10/2017
On Tuesday, the US Senate confirmed Scott Gottlieb, MD, to head the US Food and Drug Administration.
On Tuesday, the US Senate confirmed Scott Gottlieb, MD, to head the US Food and Drug Administration.
On Tuesday, the US Senate...
05/10/2017
First Report Managed Care
Asaf Kleinbort, CEO and co-founder of Medorion
Commentary
Behavior Focused Care: The Next Frontier
08/11/2021

Asaf Kleinbort, CEO and cofounder, Medorion

Asaf Kleinbort, CEO and cofounder, Me...
“The next frontier in public health will be scalable personalized communication, and it will seismically change the interactions between payer, provider, and health care recipient,” says Asaf Kleinbort, CEO and cofounder, Medorion.
“The next frontier in public health will be scalable personalized communication, and it will seismically change the interactions between payer, provider, and health care recipient,” says Asaf Kleinbort, CEO and cofounder, Medorion.
“The next frontier in public...
08/11/2021
Integrated Healthcare Executive

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

July 2013 Volume 10 Issue 7

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement